BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Cinoxacin

Cinoxacin Synthetic antimicrobial related to OXOLINIC ACID and NALIDIXIC ACID and used in URINARY TRACT INFECTIONS.

104+ PubMed studies analyzed · 9 RCTs · Evidence Score: 43.7

Research Domains

Cinoxacin has been studied across 10 research domains including 🫘 Kidney, 🧠 Focus & Attention, 🦠 Gut & Microbiome, 🔬 Oncology, 🦴 Bone & Joint. The primary research focus is 🫘 Kidney with 10% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Cinoxacin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nortriptyline
2 shared targets
scolopendra
3 shared targets
hirudo
3 shared targets
taxillus
3 shared targets
dendrobium
2 shared targets
mylabris
2 shared targets
aster
3 shared targets
prunus
3 shared targets
curculigo
2 shared targets
cuscuta
3 shared targets
Loading evidence profile...

This evidence profile for Cinoxacin is generated deterministically from 104 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.